false

Center for Clinical Tolerance

The Center for Clinical Tolerance is the world’s first center dedicated to preventing organ transplant rejection without the use of lifelong antirejection drugs.
primary
phone
877-644-2860
8776442860

The mission of the Center for Clinical Tolerance

This is the first center in the world dedicated to establishing clinical transplant tolerance as the standard of care in transplant surgery.

Transplant tolerance is an innovative method that enables the patient’s immune system to maintain the new organ without the need for long-term immunosuppressant medications, allowing for patients to reduce or even discontinue medication while still ensuring the success of the transplant. With transplant tolerance immunosuppression drug-free transplants are a possibility.

Part of Transplant Surgery

Frequently asked questions

Can a person live without one or both of their kidneys?
The kidneys are important for your health, helping to clean the blood by removing waste as urine and keeping water, salts, and minerals balanced. They also help control blood pressure and make new red blood cells. While most people have two kidneys, it is possible to live with just one. For people with kidney failure, or end-stage kidney disease, wherein the kidneys’ function is severely impaired, treatments like dialysis or a kidney transplant are needed.
What is organ rejection?
Following transplant surgery, patients typically require lifelong immunosuppressant medications to stop the immune system from attacking and, ultimately, rejecting the new organ. This rejection process naturally occurs as the immune system's main function is to protect the body from harm by identifying foreign cells and tissues—such as a virus or bacteria. It perceives these foreign “intruders” as a threat and mounts an immune response to attack them. It unfortunately also recognizes transplanted organs as foreign and targets them. Immunosuppressive medications reduce this immune response after transplant surgery to prevent organ rejection.
What are immunosuppressants and how do they prevent a rejection episode?
Immunosuppressants, or antirejection medications, are drugs that weaken the body’s ability to attack a transplanted organ. This defense system is known as the immune system.
What are the side effects of immunosuppressant medications?
While these medications are globally considered the standard of care for long-term transplant success, they are associated with significant side effects and don’t always prevent a slow form of organ rejection called chronic rejection. The impact of these medications on a patient’s quality of life can be significant and can increase the chance of infections and other complications, like cancer, heart disease, diabetes, and other metabolic diseases.
How is clinical transplant tolerance achieved?

To initiate tolerance after transplant surgery, the Legorreta Center for Clinical Transplant Tolerance at Mass General uses clinically tested treatments that combine donor bone marrow or blood stem cell transplantation with organ transplantation, which allows for the slow reduction of immunosuppressive medications after surgery. This is called simultaneous tolerance.

Our expert team infuses donor bone marrow or blood stem cells into the patient’s body at the same time as they transplant the organ. In the weeks following surgery, the cells expand and train the immune system to recognize the new organ and accept it as its own rather than attack it.

While immunosuppressive medications are still required immediately following surgery, they will be carefully and intentionally reduced over 9-18 months—sometimes, until no medication is needed at all.

Am I eligible for an immunosuppressant-free transplant if I received a kidney transplant in the past?

We also aim to eliminate the need for lifelong immunosuppression in patients who underwent kidney transplant surgery in the past. Our preclinical studies have proven that this is possible, and we are currently enrolling patients into an FDA-approved clinical trial for “Delayed Tolerance.”

This approach is possible as long as the bone marrow or blood stem cells from the original kidney donor are available. For those who received their new organ through the deceased donor waitlist, we can use the donor’s bone marrow cells if they were stored at the time of the original transplant surgery. For recipients who received their new organ through living donation, the delayed tolerance treatment is available anytime as long as their original living donor is willing and medically cleared to provide bone marrow or blood stem cells.

By completing the e-questionnaire, cctt.mghlivingdonors.org, we can start the process to determine a patient's eligibility for either the simultaneous tolerance or the delayed tolerance protocols.

Is transplant tolerance available to all organ recipients?
While delayed tolerance treatment at Mass General is currently only available for kidney transplant patients, our team is working to expand this option to include other organ recipients in the future.
What should I expect as a new patient?

Simultaneous Living Donor Transplant Tolerance Program Roadmap

  1. Once a living donor has been approved, the recipient is prepared for kidney transplantation..
  2. The recipient is admitted 1 week before transplant to start medication and thymus irradiation to prepare for transplantation.
  3. An infusion of donor bone marrow or blood stem cells is combined with kidney transplantation to induce transplant tolerance.
  4. Donor bone marrow or blood stem cells will expand in the recipient body for weeks to months after transplantation and then slowly disappear.
  5. The recipient is on immunosuppressants to prevent rejection of the transplanted kidney.
  6. Biopsy of the transplanted kidney and blood tests performed 6 months post-transplant to monitor for rejection.
  7. Following a normal biopsy, gradual reduction of immunosuppressive medication begins and is completed 1 year after transplantation.
What should I expect as former transplant patient?

Delayed Tolerance Program Roadmap

  1. After your transplant, you’ll work with the transplant team to create an action plan for your ongoing care.
  2. The recipient is admitted 1 week before transplant to start medication and thymus irradiation to prepare for transplantation.
  3. An infusion of donor bone marrow or blood stem cells is given to induce transplant tolerance.
  4. The recipient is on immunosuppressants to prevent rejection of the transplanted kidney.
  5. Biopsy of the transplanted kidney and blood tests performed 6 months posttransplant to monitor for rejection.
  6. Following a normal biopsy, gradual reduction of immunosuppressive medication begins and is completed 1 year after transplantation.
How do I schedule an appointment?
You will need to be a kidney transplant candidate to qualify for the transplant tolerance protocol. If you are a kidney transplant patient, request an appointment call 877-644-2860.

Transplant conditions and treatments

Contact the Center for Clinical Tolerance

Call us to speak with a team member who can help you understand your options and guide you to the care that is right for you. With locations throughout New England and support for patients traveling from outside the United States, we make it easier to access coordinated, expert care.
primary
phone
877-644-2860
8776442860
secondary
internal-arrow
International Patient Services

Contact information for international patients

/content/unified-xwalk/en/patients-visitors/international/for-patients/contact